Form 4: Akero Therapeutics COO Jonathan Young Sells 10,000 Shares Under 10b5-1 Plan

Akero Therapeutics' Chief Operating Officer, Jonathan Young, sold 10,000 shares of common stock at a weighted average price of $32.131, as part of a pre-arranged trading plan.

Summary

• Jonathan Young, the Chief Operating Officer of Akero Therapeutics, Inc., sold 10,000 shares of common stock on December 2, 2024.
• The sale was executed at a weighted-average price of $32.131 per share.
• The shares were sold under a pre-arranged Rule 10b5-1 trading plan established on June 25, 2024.
• The sale was part of a series of transactions with prices ranging from $31.71 to $32.50.
• Following the transaction, Mr. Young directly owns 206,286 shares.
• Mr. Young also has indirect ownership of 60,000 shares held in irrevocable trusts for the benefit of his children.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates that the sale was pre-planned and not based on any material non-public information.

Comparison to Industry Standards

• Sales by executives under 10b5-1 plans are a common practice in publicly traded companies, including those in the biotechnology sector like Akero Therapeutics.
• Companies such as Madrigal Pharmaceuticals (MDGL) and Viking Therapeutics (VKTX) also see similar filings from their executives.
• The reported price range and volume of shares sold are within typical ranges for such transactions.

Stakeholder Impact

• The sale of shares by a company executive may have a minor impact on investor sentiment, but the pre-planned nature of the transaction mitigates any significant concerns.

Key Dates

Keywords

Akero Therapeutics, Jonathan Young, insider trading, stock sale, Rule 10b5-1, AKRO, Chief Operating Officer, equity securities